Filing Details

Accession Number:
0001562180-21-005871
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-08 16:08:16
Reporting Period:
2021-09-03
Accepted Time:
2021-09-08 16:08:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1636422 Health Catalyst Inc. HCAT Services-Computer Programming, Data Processing, Etc. (7370) 453337483
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780878 Linda Llewelyn C/O Health Catalyst, Inc.
10897 South River Front Parkway, #300
South Jordan UT 84095
Chief People Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-03 1,100 $11.78 36,736 No 4 M Direct
Common Stock Acquisiton 2021-09-03 1,100 $10.80 37,836 No 4 M Direct
Common Stock Disposition 2021-09-03 3,179 $54.27 34,657 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-09-03 1,100 $0.00 1,100 $11.78
Common Stock Stock Option (Right to Buy) Disposition 2021-09-03 1,100 $0.00 1,100 $10.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,254 2028-01-24 No 4 M Direct
27,748 2028-09-27 No 4 M Direct
Footnotes
  1. The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1.
  2. Represents the weighted average sale price of the shares sold ranging from $53.86 to $54.66 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote.
  3. 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.
  4. 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.